WIERENGA WENDALL 4
4 · CYTOKINETICS INC · Filed Oct 31, 2024
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
WIERENGA WENDALL
Director
Transactions
- Sale
Common Stock
2024-10-28$52.25/sh−4,452$232,617→ 24,559 total - Exercise/Conversion
Common Stock
2024-10-28$7.37/sh+4,452$32,811→ 29,011 total - Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2024-10-28−4,452→ 1,484 totalExercise: $7.37From: 2015-02-02Exp: 2025-01-02→ Common Stock (4,452 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016.